Triple

T6250019

Position	Surface form	Disambiguated ID	Type / Status
Subject	Onora O’Neill	`E140021`	entity
Predicate	memberOf	`P10`	FINISHED
Object	Nuffield Council on Bioethics The Nuffield Council on Bioethics is an independent UK body that examines and advises on ethical issues arising from developments in biology and medicine.	`E580525`	NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini

Instruction

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Input

Phrase: Nuffield Council on Bioethics | Statement: [Onora O’Neill, memberOf, Nuffield Council on Bioethics]

NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07

Target entity: Nuffield Council on Bioethics
Context triple: [Onora O’Neill, memberOf, Nuffield Council on Bioethics]

A. Presidential Commission for the Study of Bioethical Issues
The Presidential Commission for the Study of Bioethical Issues was a U.S. federal advisory panel that provided guidance to the President on ethical issues arising from advances in biomedicine and related areas of science and technology.
B. Centre for Ethics
The Centre for Ethics is a specialized unit within the Norwegian Institute of Public Health that focuses on ethical issues in public health policy, research, and practice.
C. Human Fertilisation and Embryology Authority
The Human Fertilisation and Embryology Authority is the UK’s independent regulator overseeing fertility treatment and embryo research to ensure safety, ethical standards, and compliance with the law.
D. Committee for Advanced Therapies
The Committee for Advanced Therapies is a scientific body within the European Medicines Agency responsible for evaluating and providing expert opinions on advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies.
E. Centre for Collaboration with Ethics Networks
The Centre for Collaboration with Ethics Networks is a unit within the Norwegian Institute of Public Health that coordinates and supports cooperation among ethics committees and networks in health and research.
F. None of above. chosen
G. Unsure - the case is ambiguous/there is not enough information to decide.

NEDg Description generation gpt-5.1

Instruction

Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"

Input

Entity: Nuffield Council on Bioethics
Triple: [Onora O’Neill, memberOf, Nuffield Council on Bioethics]

Generated description

The Nuffield Council on Bioethics is an independent UK body that examines and advises on ethical issues arising from developments in biology and medicine.

NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07

Target entity: Nuffield Council on Bioethics
Target entity description: The Nuffield Council on Bioethics is an independent UK body that examines and advises on ethical issues arising from developments in biology and medicine.

A. Presidential Commission for the Study of Bioethical Issues
The Presidential Commission for the Study of Bioethical Issues was a U.S. federal advisory panel that provided guidance to the President on ethical issues arising from advances in biomedicine and related areas of science and technology.
B. Centre for Ethics
The Centre for Ethics is a specialized unit within the Norwegian Institute of Public Health that focuses on ethical issues in public health policy, research, and practice.
C. Human Fertilisation and Embryology Authority
The Human Fertilisation and Embryology Authority is the UK’s independent regulator overseeing fertility treatment and embryo research to ensure safety, ethical standards, and compliance with the law.
D. Committee for Advanced Therapies
The Committee for Advanced Therapies is a scientific body within the European Medicines Agency responsible for evaluating and providing expert opinions on advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies.
E. Centre for Collaboration with Ethics Networks
The Centre for Collaboration with Ethics Networks is a unit within the Norwegian Institute of Public Health that coordinates and supports cooperation among ethics committees and networks in health and research.
F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step	Stage	Batch ID	Status	When
creating	Elicitation	`batch_69c008b4858c819095b0199114a9a87b`	completed	March 22, 2026, 3:20 p.m.
NER	Named-entity recognition	`batch_69c0633dde348190bbf02a943d94e3be`	completed	March 22, 2026, 9:46 p.m.
NED1	Entity disambiguation (via context triple)	`batch_69c2441d4ad88190895237d834f5d9b8`	completed	March 24, 2026, 7:58 a.m.
NEDg	Description generation	`batch_69c2a571b6708190a93f750852365525`	completed	March 24, 2026, 2:53 p.m.
NED2	Entity disambiguation (via description)	`batch_69c4fb839b2481909caa57f34a8837db`	completed	March 26, 2026, 9:25 a.m.

Created at: March 22, 2026, 4:24 p.m.